Faiz Anwer, MD, a hematologist at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss CRISPR, a gene-editing technology. Listen as Dr. Anwer highlights CRISPR's advantages over traditional cellular therapies, the challenges of off-target effects, and its future in solid tumor treatment.
Faiz Anwer, MD, a hematologist at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss CRISPR, a gene-editing technology. Listen as Dr. Anwer highlights CRISPR's advantages over traditional cellular therapies, the challenges of off-target effects, and its future in solid tumor treatment.